Coding Tip: What is COPD?
Kim Carrier RHIT, CDIP, CCS, CCS-P
Director of Coding Quality Assurance
AHIMA Approved ICD-10-CM/PCS Trainer
November is COPD Awareness Month. Chronic obstructive pulmonary disease is commonly referred to as COPD by patients and physicians. Let’s look at what COPD is and what causes this disease.
What is COPD?
COPD is a respiratory condition where there is chronic obstruction to airflow in the lungs. Air is breathed into the lungs but a patient with COPD has trouble emptying air out of the lungs. This can also cause patients with COPD to have CO2 retention. COPD is an irreversible and progressive disease in which the lung function worsens as time goes on. Once the disease becomes symptomatic the progression may be fast and relentless depending on the treatment that the patient agrees to and the lifestyle changes made. Once the diagnosis of COPD is given to a patient this would be coded (when documented) for the rest of the patient’s life since there is no cure for this disease at this time. There are treatments for COPD that help in progression but they do not cure the disease. COPD is the 3rd leading cause of death in the U.S.
Emphysema and chronic bronchitis are specified types of COPD. Chronic bronchitis is when there is increased mucous and swelling production in the airway. When this occurs the breathing tubes become smaller than normal and it is difficult for the patient to get or take a good breath. Emphysema involves damage to the walls of the alveoli of the lung. When the walls are damaged the alveoli lose their ability to stretch and spring and the air gets trapped. Since the term COPD is unspecified and represents any form of unspecified chronic obstructive lung disease, an additional code is not needed when the diagnosis of emphysema is documented in the healthcare record. The emphysema is the specified type of COPD. Asthma is not included in the definition of COPD but it is not uncommon for patients with COPD to also have asthma.
Symptoms of COPD:
- Shortness of breath
- Persistent coughing/chronic coughing
- Increased sputum/mucous production
- Wheezing and a tight feeling in the chest
Causes of COPD:
- Smoking (75% of people with COPD smoke or have smoked)
- Second hand smoke
- Genetics (alpha-1 antitrypsin deficiency)
- Heavy exposure to chemicals or dust
- Indoor and outdoor pollution
Treatment for COPD:
- If you smoke…STOP
- Bronchodilators given by your physician
- Anti-inflammatory drugs (steroids) given by your physician
- Antibiotics to treat exacerbations
- Oxygen when the oxygen in the blood is low
- Lung volume reduction surgery
- Lung transplantation
- Pulmonary rehabilitation
- Support groups
In order to properly treat COPD and control some of the symptoms and reduce the exacerbations, the patient must be compliant with their medications. These must be taken daily or however often prescribed. Each patient is different in their needs. The medications will be needed for life.
- A patient is documented in the record to have COPD and emphysema throughout. Should both diagnoses be coded? No. Per the ICD-10-CM Alphabetic Index, only J43.9-Unspecified emphysema is reported. Remember emphysema is a specific type of COPD.
- A patient is documented in the record to have COPD and also has a diagnosis of chronic bronchitis and is on long term medications to help keep the chronic bronchitis from exacerbations. In this case, only code J44.9- Chronic obstructive pulmonary disease, unspecified is reported following the ICD-10-CM Alphabetic Index.
- A patient is admitted with acute bronchitis and also has a history of COPD. Does this mean that the COPD is automatically considered to be in exacerbation? No. Should both diagnoses be coded? Yes. In this case, J44.0-Chronic obstructive pulmonary disease with acute lower respiratory infection and J20.9- Acute bronchitis, unspecified would be reported. If the record further specified that the COPD was in exacerbation, then a third code would also be reported to fully describe and report the diagnoses documented – J44.1-Chronic obstructive pulmonary disease with (acute) exacerbation.
If you need help to quit smoking, please call the National Cancer Institute’s Smoking Quitline for support at 1-877-44U-QUIT.
ICD-10-CM Official Guidelines for Coding and Reporting FY 2019 Page 52
ICD-9-CM Coding Clinic, July-August 1984 Page: 17 to 19
ICD-9-CM Coding Clinic, Third Quarter 1988 Page: 5 to 6
ICD-10-CM/PCS Coding Clinic, Fourth Quarter ICD-10 2017 Page: 97
ICD-9-CM Coding Clinic, Fourth Quarter 1993 Page: 26
ICD-9-CM Coding Clinic, Second Quarter 1992 Page: 16 to 17
The information contained in this coding advice is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.
With the implementation of ICD-10-CM came different codes and coding rules for many diagnoses. One of these is the coding of bowel obstruction when the patient presents for this condition that is caused by another condition.
This is Part 5 of a five part series on the new 2021 CPT codes. For the remaining areas we will just briefly summarize the section. Due to the intricate nature of these sections in CPT, it is recommended that the coder read the entire section notes associated with the new codes.
This is Part 4 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes in the urinary, nervous, ocular and auditory systems. There are 2 new urinary/male reproductive system codes with no revisions or deletions; 3 new female reproductive codes with 2 deletions, 0 new with 4 deleted nervous system codes with 5 revisions; 5 new eye category III codes; and finally a 2 new auditory codes with one deletion.
This is Part 3 of a five part series on the new 2021 CPT codes. In this series we will explore the cardiovascular system CPT changes. There are 5 new cardiovascular CPT codes added with 0 deletions and 4 revisions.
This is Part 2 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include some examples to help the coder understand the new codes. There are 0 new musculoskeletal CPT codes added with 0 deletions and 2 major revisions along with an extensive update to arthroscopic loose body removal requirements. For the respiratory system, there were 2 new codes, one code deletion and no revisions.
This is Part 1 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include examples to help the coder understand the new codes. For 2021 in general, there were 199 new CPT codes added, 54 deleted and 69 revised.
In January, new CPT codes were released. There were 248 new CPT codes added, 71 deleted and 75 revised. Most of the surgery section changes were in the musculoskeletal and cardiovascular subsections. These included procedures such as skin grafting, breast biopsies, deep drug delivery systems, tricuspid valve repairs, aortic grafts and repair of iliac artery.
We have seen many updates and changes to COVID-19 (SARS-CoV-2) since the pandemic started. On January 1, 2021 we will see even more changes as outlined in this post. Also the CMS MS-DRG grouper will be updated to version 38.1 to accommodate the changes.
In the previous three parts of this four-part series, we discussed the new ICD-10-CM diagnosis code changes, ICD-10-PCS procedure code changes and FY2021 IPPS changes. In this last Part 4 of the series, we will review the NTAP procedure codes and reimbursement add-on payments for FY2021.
In the previous two parts of this four part series, we discussed the new ICD-10-CM diagnosis code changes and ICD-10-PC procedure code changes. In this session we will review the major IPPS changes for FY2021.
This is Part 2 of a 4 part series on the FY2021 ICD-10 Code and IPPS changes. In this part, the ICD-10-PCS procedure codes are presented. For FY2021 ICD-10-PCS there are 78,115 total codes (FY2020 total was 77,571); 556 new codes (734 new last year in FY2020)…
This is Part 1 of a 4 part series on the FY2021 changes to ICD-10 and the IPPS. In this part, we discuss some of the new ICD-10-CM diagnosis changes. Here is the breakdown: 72,616 total ICD-10-CM codes for FY2021; 490 new codes (2020 had 273 new codes); 58 deleted codes (2020 had 21 deleted codes); 47 revised codes (2020 had 30 revised codes)
Acute pulmonary edema is the rapid accumulation of fluid within the tissue and space around the air sacs of the lung (lung interstitium). When this fluid collects in the air sacs in the lungs it is difficult to breathe. Acute pulmonary edema occurs suddenly and is life threatening.
“Client S” is a small, not-for-profit, 40 bed micro-hospital in the Southeast. HIA performed a 65-record review this year for Client S and found an opportunity with 15 of them. 9 had an increased reimbursement with a total of $43,228 found.
The coma scale codes (R40.2-) can be used in conjunction with traumatic brain injury codes, acute cerebrovascular disease or sequelae of cerebrovascular disease codes. These codes are primarily for use by trauma registries, but they may be used in any setting where this information is collected. The coma scale may also be used to assess the status of the central nervous system for other non-trauma conditions, such as monitoring patients in the intensive care unit regardless of medical condition.
In the past, there had been an Excludes1 note at I46.- Cardiac arrest that excluded R57.0, Cardiac shock. HIA had also received a letter from AHA on a case in the past that had stated that only I46.- Cardiac arrest would be coded if both were documented. In addition, the Third Quarter Coding Clinic page 26 had a similar case that asked if both could be coded, and AHA had instructed that only I46.9, cardiac arrest, cause unspecified would be coded if both were documented and that the CDC would be looking at possible revision to the Excludes1 note.
A higher CMI corresponds to increased consumption of resources and increased cost of patient care, resulting in increased reimbursement to the facility from government and private payers, like CMS. We know that documentation directly impacts coding.
Lately we have seen several cases where the endarterectomy was assigned along with the coronary artery bypass (CABG) procedure when being performed on the same vessel to facilitate the CABG. A coronary artery endarterectomy is not always performed during a CABG procedure, so when it is performed it becomes confusing as to whether to code it separately or not.
Assign code Z20.828, “Contact with and (suspected) exposure to other viral communicable diseases” for all patients who are tested for COVID-19 and the results are negative, regardless of symptoms, no symptoms, exposure or not as we are in a pandemic.
The Centers for Medicare & Medicaid Services (CMS) announced new procedure codes for treatments of COVID-19 – effective as of August 1, 2020. Among the new codes are Section X New Technology codes for the introduction or infusion of therapeutics including Remdesivir, Sarilumab, Tocilizumab, transfusion of convalescent plasma, as well as introduction of any other or new therapeutic substances for the treatment of COVID-19.
One common element in many value-based programs is risk adjustment using Hierarchical Condition Categories (HCCs) to create a Risk Adjustment Factor (RAF) score. This method ranks diagnoses into categories that represent conditions with similar cost patterns.
Why are so many AKI records being denied? It’s hard to give one answer for why so many AKI records are being denied lately, but most appear to be due to the multiple sets of criteria available for use in determining if a patient has AKI, as well as physician documentation. As stated in Part 3 of this series, there are three main criteria/classifications used to diagnose AKI.
In previous parts of this series we looked at the definitions of AKI/ARF, causes, coding and sequencing, and the common clinical indicators that patients present with that are diagnosed with this condition. In Part 4, we will look at the documentation that should be present to report the diagnosis without fear of denial, as well as when a query is needed to clarify the diagnosis.
In the first parts of this series we looked at definitions of AKI/ARF, causes, coding and sequencing. In Part 3, we will look at what clinical indicators would possibly be present to support the diagnosis of AKI/ARF.
The FY2021 IPPS Proposed Rule is out and here are some highlights from it regarding ICD-10 Code proposals. We will know if these changes are permanent after the public comment period is over on July 10, 2020 and CMS prepares the Final Rule, usually out by August 1.
As discussed in Part 1 of this series, AKI/ARF is a common diagnosis that coders see daily. In Part 2, we are going to focus on the different types/specificity of AKI/ARF. We’ll learn what they mean, as well as how to code the diagnosis.
This is part 1 in a series focused on coding of acute kidney injury (AKI) and/or acute renal failure (ARF). AKI/ARF is reported often, but is also one of the most common diagnosis found in denials.
With the proliferation of COVID-19 cases, we thought we would put together a quick reference listing of some of the common scenarios that coders have asked about. As with all coding, coders should follow Official Guidelines for Coding and Reporting and the COVD-19 Frequently Asked Questions document by the AHA.
Effective March 1, Medicare will pay physicians for telehealth services at the same rate as in-person visits for all diagnoses, not just services related to COVID-19. This great for providers whose patients are reluctant to visit the office.